Table 1 Papilloma incidence in the congenic lines
Congenic line | Chromosomal region (cM) a | Backcross | Intercross | ||||
---|---|---|---|---|---|---|---|
NS b | NN b | P-valuec | SS b | NN b | P-valuec | ||
3540 | 15.4–28.9 | 12.5 (1–33; n=20) | 22 (4–38; n=18) | 2.4E-03 | 6 (1–21; n=14) | 15 (2–28; n=20) | 8.0E-04 |
A62 | 18–28.9 | 11 (0–32; n=19) | 22 (4–36; n=19) | 2.1E-03 | 4 (0–19; n=16) | 15 (2–32; n=15) | 5.3E-04 |
717 | 18–21.8 | 14 (0–32; n=17) | 24 (14–35; n=13) | 1.5E-03 | 6 (0–19; n=17) | 15 (4–27; n=19) | 1.9E-04 |
B6F | 18–19.3 | 17 (5–31; n=12) | 20 (5–41; n=14) | 0.16 | 14 (0–36; n=17) | 14 (4–28; n=16) | 0.40 |
C3F | 20.9–28.9 | 6.5 (0–29; n=12) | 22.5 (4–36; n=18) | 4.6E-03 | 2 (0–11; n=13) | 17 (4–32; n=16) | 2.9E-05 |
454 | 25.4–28.9 | 20 (2–37; n=13) | 23 (6–41; n=19) | 0.24 | 15 (2–28; n=16) | 12 (1–27; n=23) | 0.19 |
314 | 27.6–28.9 | 18.5 (4–34; n=8) | 23 (6–36; n=11) | 0.15 | ND | ND | ND |
D0F | 1.7–19.3 | ND | ND | ND | 10 (1–21; n=19) | 14.5 (1–31; n=22) | 0.03 |
150 | 15.4–17 | ND | ND | ND | 10 (1–20; n=17) | 15 (2–33; n=17) | 0.03 |
260 | 15.4–18 | ND | ND | ND | 11 (0–20; n=16) | 12 (3–24; n=26) | 0.16 |
381 | 20.9–25.4 | ND | ND | ND | 5.5 (0–17; n=26) | 14.5 (4–27; n=20) | 3.7E-05 |
383 | 20.9–26.7 | ND | ND | ND | 1 (0–10; n=23) | 13.5 (4–45; n=22) | 1.4E-08 |
1230 | 20.9–21.8 | ND | ND | ND | 8 (0–29; n=16) | 25 (20–32; n=10) | 2.4E-04 |